Format

Send to

Choose Destination
J Law Med Ethics. 2019 Jun;47(2):347-349. doi: 10.1177/1073110519857293.

Orphan Drug Designation and Exclusivity for "Same Drugs".

Author information

1
Phebe Hong is at the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, and a student at Harvard Law School. Ameet Sarpatwari, J.D., Ph.D., is at the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Aaron S. Kesselheim, M.D., J.D., M.P.H., leads the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
PMID:
31298092
DOI:
10.1177/1073110519857293

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center